chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Next period after received the vaccine was completely off; Bled longer, heavier and was accompanied with painful headaches and cramps.; Bled longer, heavier and was accompanied with painful headaches and cramps.; It has been 4 months since and periods are still irregular but no longer last 10 days; Bled longer, heavier and was accompanied with painful headaches and cramps.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14May2021 at 15:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and vitamins (unspecified); both for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 15:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 22May2021, the next period after the patient received the vaccine was completely off. The patient bled longer, heavier and was accompanied with painful headaches and cramps. It had been four months since, and her periods were still irregular but thankfully no longer lasted ten days. The patient was still dealing with significantly more bleeding with her periods but at least it had slowed somewhat from before. It had been the only lasting effect the patient had but was highly concerning and frustrating. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events next period after the patient received the vaccine was completely off; bled longer, heavier and was accompanied with painful headaches and cramps and it has been four months since and her periods are still irregular but no longer last ten days was unknown at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Unfortunately his COVID swab came back positive positive the local emergency department for evaluation of shortness of breath, weight gain, afib RVR, and not "snapping back as quickly as before".
Within 12 hours or so the following effects were noted.  This was the second injection.  Both injections had similar effects.   1. Injection site soreness/tenderness for up to 3 days.  Note : Different arm this time. 2. General soreness throughout my body. 3. Intense and long headache that lasted for up to 36 hours.  Acetominophen and ibuprophen taken in series after approximately 20 hours. 4. Fever up to 100.5 F & chills for up to 2 days. 5. Some nausea for 2 days. 6. General feeling of lack of concentration and being "hazy" in general condition.
Extremely sore arm at injection site with pain that radiated into shoulder and rotator cuff. Pain and weakness in shoulder that inhibited strength and range of motion. Lasting pain and weakness in shoulder that remains >1 month after the vaccination. Difficulty lifting heavy objects with this arm.
Developed rash and itching at injection shot.  Lasted about 2 or 3 days.  Put cortisone salve which helped
This spontaneous report as received from a Nurse refers to a patient of unknown age. On an unknown date the patient was vaccinated with VAQTA (lot# was not reported) which were improperly stored. No adverse events was reported. Additional information has been requested.
This spontaneous report has been received from a nurse, concerning a 46 year old male patient. The patient's medical history, concurrent conditions and concomitant medications were unknown by reporter. In approximately 1993 (reported as when he was either 22 or 23 years of age), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown) and on the same date in 1993, the patient was also vaccinated with another unspecified vaccine (manufacturer unknown) (dose, frequency, route, lot# and expiration date not reported for any vaccine) for prophylaxis. On an unknown date after receiving the vaccines of pneumococcal vaccine, polyvalent (23-valent)(manufacturer unknown) and the another unspecified vaccine, the patient got very sick. The patient sought medical attention and received an unspecified treatment. There was unknown if any laboratory or study were performed. The outcome of got very sick was reported as recovered. The causal relationship between got very sick and the therapies was not assessed.
This spontaneous report was received from a pharmacist and refers to a 62 year old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-SEP-2017, the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # L019836 with an expiration date 24-MAR-2017 for prophylaxis (dose and route of administration were not reported). No adverse effects was reported. There was no product quality complaint reported.
Healthy client received Menactra 0.5 cc IM L Deltoid at 4PM on 07/12/07 without incident. Mother of client reported the following information at 4PM on 07/17/07.  Onset of symptoms during the night of 07/12/07- fever of 100-101 degrees F, nausea, stiff neck, blurred vision, sore L arm, generalized joint aching  severe headache,malaise, sl. mental "fogginess," without seizure paralysis, generalized rash or vomiting.  Parents gave client tylenol as needed to reduce aching and fever symptoms over the course of next 3 days, during which time client was not able to go to work due to symptoms, but was able to lay on the couch and eat some foods and liquids. At 4PM on 7/17/07 mother reports client is "Slowly getting better-she was able to go to work today, but she's still tired and the L arm is still tender.  The headache is going away, too.  Interestingly, my sister's son had the Menactra vaccine last summer, and she just told me that her son had three days of fever and aching when he had it, too."  I encouraged mother to call Dr. to report the adverse symptoms and any symptoms that may occur in the future related to the vaccination. Mother agreed to contact Dr. as follow up to incident.
#2 MMR administered expired lot # MSD 0377R (3/24/07) couldn't update in LINKS
Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Details surrounding death on 3/17/21 not known. Pulmonary Note dated 2/17/21 detailed condition getting worse w/ increasing shortness of breath. He had a 40 PPY smoking history with interstitial lung disease, HTN, ITP, PVD. He required 3 L of oxygen.
Date of Admission:  1/18/2022   Chief Complaint:  Shortness of breath, blood in stool   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 55y.o. male with a past medical history significant for hypertension, ESRD on dialysis Monday Wednesday Friday, and diabetes.  He presents to hospital on 1/18/2022 for evaluation of shortness of breath.  He states that he has missed his 2 most recent dialysis treatments on Friday and Monday.  He states that he will only receive treatment on Wednesday for approximately 1 hour before having to stop secondary to blood pressure issues.  He notes that there is an issue with his transportation getting to his dialysis sessions.  He states that as of yesterday he began noticing he was having increased shortness of breath which has been worsening over the preceding days.  He also admits to baseline orthopnea which has been present for the preceding months.  He states that he does take a water pill at home however he has decreased urinary response to a due to his ESRD, notes only approximately 100 to 200 mL is produced.  He states that his family has a history of congestive heart failure states that he had a echo approximately 2 years ago which was normal to his knowledge.  Denying any chest pain.  He does not endorse cough.  He also notes some increased lower extremity swelling.  He is currently denying any chest pain. Denies any fevers, chills.  He endorses occasional nausea but denies any episodes of emesis.  He states that he noticed blood on the toilet paper after wiping for the last few days.  He states that he did not see blood on his stool.  He denies any recent weight loss or weight gain.  States that he had a colonoscopy approximately 2 to 5 years ago that was normal to his knowledge this is a follow-up and 10 years after the original colonoscopy.  Denies any pain with bowel movements.  Denies any family history of colon cancer.  He admits to normal oral intake along with a normal bowel pattern.  Denies any urinary symptoms.  He states that he is vaccinated for COVID and received his second vaccination shot approximately 1 month ago.
w/in 24hr of vax rt arm was swollen from the shoulder to the fingers;it was hot, red & irritated @ site as well as very painful;pt recv 5 days of vax;all sx resolved by 21MAY97;
12/22 vaccination 12/23 8-10PM  fever, feeling poorly, and vomiting thereafter. Rotated between the tylenol and motrin. Vomiting 1 episode. Fever 24-48 hours after vaccination. 2 days poorly.
Severely sore joints all over; Achilles tenden pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) at the age of 48 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Misplaced/discarded, Location of injection: Arm Left), when the patient was 48 years old, for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 10Nov2021, outcome "not recovered", described as "Severely sore joints all over"; TENDONITIS (non-serious) with onset 10Nov2021, outcome "not recovered", described as "Achilles tenden pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of arthralgia, tendonitis.  The lot number for bnt162b2 was not provided and will be requested during follow up.
negative reaction; This spontaneous case was reported by a pharmacist and describes the occurrence of ADVERSE REACTION (negative reaction) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information provided by reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (negative reaction). At the time of the report, ADVERSE REACTION (negative reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant or treatment medications provided by reporter. Reporter states the consumer does not want to receive the second dose of Moderna vaccine due to negative reaction that happened after first dose. The consumer would like to receive the Pfizer Covid-19 vaccination as her second dose but has not done so yet.    Reporter did not allow further contact
I started feeling slightly unwell the night I received the vaccine and took two Tylenol before going to bed.  When I woke up on Saturday morning, I had a Migraine, fever of 99.9 and generally felt unwell.  I took two Tylenol and and an Imitrex and stayed in bed.  Over the course of the day, my fever went up gradually to 101.8 and I felt achy.  I took Tylenol every six hours.  I stayed in bed all day Saturday and when I woke up Sunday, the fever was gone but the Migraine was back.  I took another Imitrex and felt almost normal within an hour.  I've had no other reactions at this point.
My arthritis pain is gone; vivid dreams; This is a spontaneous report from a contactable consumer.  A 64-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3246), via an unspecified route of administration on 12Jan2021 09:00 at a single dose for covid-19 immunization. The patient's medical history included allergy to IVP DYE, and osteoporosis from an unknown date. Concomitant medication included alendronate sodium (ALENDRONATE).  The patient previously took varicella zoster vaccine (shingles vaccine on 03Dec2020), and povidone in generic tablets and experienced allergy. On 15Jan2021, the patient experienced her arthritis pain was gone. The patient also mentioned that she had vivid dreams in Jan2021 and haven't dreamed in years. The outcome of the event swas unknown. The patient did not received treatment for the event. The patient diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination.
Bursitis; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Lot number: GK1337) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization Series Completed, Unknown Manufacturer), for Covid-19 immunization. The following information was reported: BURSITIS (non-serious), outcome "unknown".  No follow-up attempts are possible. No further information is expected.
Swollen tight painful throat. Given 50mg Benadryl and 150mg Zantac symptoms improved over 20-30 minutes.
Systemic: Dizziness / Lightheadness-Mild, Systemic: seizure for 30 sec on next day-Mild
Vaccine was administered 5 days after vial expiration date. Parent notified by provider. Provider chosen not to revaccinate. Parent agreed, child doing well.
Low grade fever. This is my first day of fever, so I don't know if this will continue.
Pt received varivax in the left arm SQ and had a blood draw. Five minutes later she felt nauseous and dizzy and was pale. BP was decreased from 90/60 to 80/40. She had weak pulse and cool extremities. She was layed flat and given O2 X 5-10 minutes. She then recovered and was transferred to ER and observed briefly and was discharged home.
pt recv vax; soreness occurred; lump & redness around area;size of an orange;still present; pt felt was fr tetanus vax;
Approx. 36 hours after the first shot, I noticed an intense ringing in my ears that has not gone away. For the first 48 hours I also experienced dizziness, confusion, mood swings, and soreness in my arm. I still have occasional dizziness and mild vertigo.
Constant ringing in both ears (tinnitus), balance issues, vertigo, and vision issues where the environment appears to be bouncing around known as oscillopsia.
Patient received first dose of the COVID vaccine and was monitored for 30 minutes, felt fine at that time and was allowed to leave. Approximately one hour after receiving the vaccine patient experienced right side of neck and face up to eye becoming numb and tight. Tongue got a little numb also. Over the next two hours the symptoms lightened up and by morning just felt like she had a numbing agent at the dentist along right lip, nostril and check.
only the diluent of Priorix was administered to a patient; only the diluent of Priorix was administered to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 12-month-old male patient who received MMR (Priorix) (batch number aa25f, expiry date 01-NOV-2024) for prophylaxis.   On 08-AUG-2023, the patient received Priorix. On 08-AUG-2023, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: only the diluent of Priorix was administered to a patient) and inappropriate dose of vaccine administered (Verbatim: only the diluent of Priorix was administered to a patient).The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 12-SEP-2023 The reporter was a clinical manager. The reporter reported that only the diluent of Priorix was administered to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.
26 doses administered to adult patients from pediatric vials instead of bivalent vaccine; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 08-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine).    No concomitant medication was provided.  It was reported that on 8 Oct 2022, 9 Oct 2022 and 10 Oct 2022, they administered 26 doses to adult patients from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster.   Treatment medication was not provided by the reporter.  This case contains information about patient-5 out of 26 patients.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Decreased mobility and pain-Medium, Systemic: Joint Pain-Medium, Additional Details: Patient stated injection was very painful the moment she recieved it. After about a week she followed up with her physician who diagnosed her with joint/shoulder pain due to incorrect injection of a vaccine. Patient has recieved a steroid injection and a medrol dose pack. I will follow up with patient in a few days to see if symptoms have resolved.
pt devel tremors rt arm-diarrhea c/o stomachache-temp 99-incontinent of urine;
Pfizer 3/2/21, 3/23/21. Positive on 10/3/22
Information has been received from a certified medical assistant concerning a 6 year old female consumer who on 01-APR-2008 was inadvertently vaccinated with zoster vaccine live (Oka/Merck). The patient received unspecified concomitant vaccinations. Subsequently, the patient was take to the emergency room for localized redness of both the left arm and the right arm. It was unspecified if lab studies were performed. The child was not hospitalized. The CMA reported they did not give the vaccination at that office. At the time of the report the patient's status was unknown. There was no product quality complaint involved. No further information is available.
Delayed allergic reaction (rash) atinjection site. Irregular shape butaround 1.5in in length and 1in inwidth; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 at 09:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history were not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications included  ethinylestradiol, norgestimate(ORTHO TRI-CYCLEN LO) and omega 3, greens supplement . The patient did not receive any other vaccines within four weeks prior to the vaccination .Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 at 06:00, the patient had delayed allergic reaction (rash) at injection site which was of irregular shape but around 1.5in in length and 1in in width. The patient did not receive any treatment for the event. The clinical outcome of the event delayed allergic reaction (rash) at injection site  was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected. .
1. chronic hives hives started morning after vaccine with hives localized to injection site. hives continued to spread and worsen over time.  hives did not dissipate with to anti-histamine drugs. drugs tried include zyrtec, allegra, benadryl, hydroxyzine, famotidine, doxepin, montelukast, prednisone beginning 06/23/2021 started on xolair injections. xoliar injections stopped the hives. weaned of anti-histamine cocktail in august. continuing treatment of xolair  2. menstrual abnormalities patient on Junel 1 MG 20 beginning  02/17/2021. continuous use birth control with no placebo. spotting started day of vaccine. spotting continued for months despite hormonal birth control OB prescribed higher dose birth control Junel FE 1.5 MG 30 started on 04/09/2021 OB prescribed Junel 1.5 twice per day to help control bleeding.  06/22/2021, OB prescribed Alyacen 1-35. This was day prior to first Xolair injection on 06/23/2021 Bleeding stopped on 07/07/2021. Patient remains on Alayacen 1-35.
Patient should have received her first COVID-19 monovalent vaccine, and instead received a bivalent vaccine.  No adverse event reported by the patient.  Plan to have her return for Pfizer monovalent vaccine in 21 days, and then in two months she would be eligible for the bivalent booster.
Patient went next day to urgent care -> had shortness of breath, fever, blood ok per MD, 6 cm diameter redness around shot area non productive cough.
PHARMACY LEFT PFIZER VACCINE VIALS IN THE FREEZER FOR LONGER THEAN 2 WEEKS AT A TEMPERATURE (-25 AND -15 DEGREES C). WE GAVE DOSES OUT OF THESE VIALS, RENDERING THEM POSSIBLY LESS EFFECTIVE.
Cellulitis around injection site. Resolved in 24 hours with q6 x therapy.
Chills, body aches (moderately severe; did not take temperature) headache; loss of appetite. Occasional shooting pain down leg or arm (happened about 3 times; each episode lasted about .5 - 1 minute; these symptoms lasted through the evening; headache persisted until next a.m. but fever seemed to be gone. Occasional twitching of muscles around injection site the following day; took nighttime cold medicine before going to bed and Tylenol the following morning.